Ocular Histoplasmosis Syndrome

Dean B. Burgess

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


The Macular Photocoagulation Study (MPS) is a multi-center clinical trial supported by the National Eye Institute whose purpose is to assess argon laser photocoagulation as a treatment for choroidal neovascular membranes (NVMs) that do not involve the fovea. The MPS documented that in patients with ocular histoplasmosis syndrome argon laser photocoagulation in comparison with no treatment can reduce the risk of severe visual loss from 46 to 13% in the first two years. Accordingly, patients with ocular histoplasmosis and NVMs outside the fovea are advised to undergo prompt treatment with argon laser photocoagulation.

Original languageEnglish
Pages (from-to)967-968
Number of pages2
Issue number7
StatePublished - 1986


  • laser treatment
  • ocular histoplasmosis
  • photocoagulation


Dive into the research topics of 'Ocular Histoplasmosis Syndrome'. Together they form a unique fingerprint.

Cite this